Effect of Flaxseed on Lipid Uptake and Appetite

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

18 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-10-31

Study Completion Date

2007-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Randomized trial to test the effect of flaxseed fractions on appetite regulation and intestinal lipid absorption.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Flaxseed Mucilage and Satiety

NCT01238744

Appetite

UNKNOWN NA

The Effects of Flaxseed Supplement on Weight and Biochemical Factors in Overweight and Obese Subject

NCT02410668

Overweight and Obesity

COMPLETED PHASE2/PHASE3

Effects of Flaxseed Supplementation in Metabolic Syndrome

NCT02497352

Metabolic Syndrome

COMPLETED PHASE2/PHASE3

The Effects of Flaxseed Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

NCT02395900

Non Alcoholic Steatohepatitis

COMPLETED PHASE2/PHASE3

Biomarkers in Post-Menopausal Women Receiving Flaxseed

NCT01698294

No Evidence of Disease

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Randomized multiple crossover trial in 18 healthy males aged 18 to 40 years each are required to complete a total of five iso-caloric meal tests lasting approximately 8½ hours. Test meals will be given as breakfast meals, in which different fractions of flaxseeds are incorporated into baked products. Appetite will be registered using visual analogue scales during 7 hours after the test meal and a total of 10 blood samples will be drawn to evaluate TAG in chylomicrons, plasma LDL, HDL and total cholesterol, plasma TAG, insulin, glucose and appetite hormone levels. At the end of the test day an ad libitum meal will be served and food intake registered.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Whole flaxseeds, flaxseed mucilage, glucomannan

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy males aged 18-40 years
* Normal weight or moderately overweigh (BMI 25-30 kg/m2)

Exclusion Criteria

* Blood drawing/donation less than six months prior to start of the study
* Hemoglobin concentration \<8mmol/L
* Chronic diseases (i.e. diabetes, CVD), hypertension, hyperlipidemia
* Consumption of dietary supplements including vitamin tablets
* Smoking
* Excess physical activity (\>10h of intense physical activity per week)
* Medicine use (not including occasional consumption of pain killers)

Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes